McEvoy Ashley purchased $162K of PODD

McEvoy Ashley (President and CEO) purchased 1,100 shares of INSULET CORP (PODD) at $147.47 ($0.16M total) on 2026-08-21.

Original reporting
SEC EDGAR · McEvoy Ashley
Published Aug 24, 2026, 11:08 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 11:13 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PODD
Neutral
medium confidence
Mentioned
$PODD
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PODDNeutralLow
01

Why it matters

The purchase modestly raises insider ownership, offering a slight confidence cue but unlikely to move the stock significantly.

02

Market read

A small insider buy provides a minor bullish hint for PODD but limited trading relevance.

03

What to watch

Potential upcoming product launches or regulatory news not disclosed in the filing.

Relevance 5/10Novelty 4/10Timing: filing date 2026-08-24

Background

Form 4 filings disclose insider trades; investors watch for material changes in insider holdings.

Company-level read

Ticker impact

$PODDNeutralMedium confidence
Context

President and CEO Ashley McEvoy bought 1,100 shares for $162,217, increasing his stake to 23,731 shares.

Expected impact

Minor upward pressure, likely limited to short-term sentiment.

Evidence & confidence

Form 4 is primary source; purchase amount is under $1M for a mid‑cap, so impact is small.

Market effects

Insulet operates in medical devices; insider buying may be noted by sector analysts but no broader effect.

US market only; no regional ripple.

Limited to investors tracking Insulet.

Counterpoint

Insider purchase could be a routine portfolio rebalancing, not a strong bullish signal.

Key entities

  • Insulet Corp

    Medical device maker listed as PODD.

  • Ashley McEvoy

    President and CEO of Insulet.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PODDMedAI 8/10

Insulet Corp (PODD) Q3 2026 Earnings Call Highlights: Revenue Up 19%, EPS Jumps 60%

Insulet Corp (PODD) reported Q3 2026 revenue up 19% and EPS up 60%. US new customer starts were flat, while global growth was low single-digits. The company expects 2027 growth to be modestly below mid-teens due to tougher comparisons and increased competition. Free cash flow for 2026 is expected to be $275 million. PBM negotiations for 2027 are ongoing, creating some uncertainty. The company plans to launch Omnipod 6 in 2027, with features aimed at improving clinical outcomes and lifestyle fit.